Hamilton Lenox

Hamilton Lenox is a seasoned executive in business development and operations within the pharmaceutical and biotechnology sectors. Currently serving as Senior Vice President at LGM Pharma since December 2018, Hamilton played a key role in the acquisition of Nexgen Pharma's formulation development and manufacturing business. Prior experience includes leadership positions at CPC Scientific, Nitto Denko Avecia Inc., Neuland Laboratories, Inogent Laboratories, Goodwin Biotechnology, Regis Technologies, and Polium Technologies, where Hamilton consistently drove business growth and expanded client relationships across various segments of contract development and manufacturing. Hamilton holds a Master of Science in Biochemistry from Northwestern University, an MBA in International Business from Florida International University, and a Bachelor of Science in Chemistry from DePaul University.